Russell Bialecki, PhD, FRSB, DSP

Commander
DISC Type : D

Senior Scientific Director, Early Therapeutic Area Lead, CVM at The Janssen Pharmaceutical Companies of Johnson & Johnson

Greater Philadelphia, United States

Overview

Russell Bialecki is a Senior Distinguished Scientist at Johnson & Johnson with over 20 years of experience in non-clinical research and drug development. A Research Fellow from Harvard Medical School, his expertise lies in pharmacology and toxicology, with a focus on cardiovascular, metabolism, and pulmonary hypertension. He holds both FRSB and DSP certifications.

He founded his own specialized consulting firm, PharmaSC, LLC, to advise clients on mitigating human safety issues in early clinical development.

Personality Overview

Decisive

Very Quick

Candid & Clear

They like to act fast and expect others to do the same.  They are not focused on building rapport and relationships. They respond better to strong and respectful interactions.

Topics They Care About

Pulmonary Hypertension
A core focus of his current role at Johnson & Johnson and a subject of his recent company communications and past publications.
Preclinical Safety
His career is centered on safety pharmacology and toxicology, including founding a consultancy to mitigate human safety issues in drug development.
Cardiovascular Research
Leads the Cardiovascular and Metabolism therapeutic area, with extensive experience in designing and interpreting nonclinical safety studies for these conditions.

Media Appearances

Russell has no verified media appearances

Work History

1-2020
Senior Scientific Director, Early Therapeutic Area Lead, CVM at The Janssen Pharmaceutical Companies of Johnson & Johnson
1-2020
Sr Scientific Director & Therapeutic Area Lead, Cardiovascular, Metabolism, Pulmonary Hypertension at The Janssen Pharmaceutical Companies of Johnson & Johnson
1-2019 - 1-2020
Founder and Principal at PharmaSC, LLC
10-2017 - 1-2019
Director, Haskell Global Center for Health Sciences at DuPont
5-2015 - 9-2017
Technical Manager, Human Safety Assessment at DuPont

Education

1988 - 1991
Research Fellow in Medicine and Post-Doctoral Research Fellow from Harvard Medical School
B.S. from Duquesne University

More Information

Social Presence :

Prographics :

Exp : 17 Location : Greater Philadelphia, United States Job Level : Senior Designation : Senior Scientific Director, Early Therapeutic Area Lead, CVM at The Janssen Pharmaceutical Companies of Johnson & Johnson
URL has been copied!

Insights For Selling To Russell

During A Call Or A Meeting

DO's

  • Objectively showcase the impact that your product creates
  • Use phrases like ‘it’s your decision’, ‘strategic impact’ etc.
  • Make sure that you circle back fast on any action items, it wins their trust

DONT's

  • Don’t focus on process and rules, give the impression of being a ‘gets it done’ person
  • Do not back off when challenged, respond with a confident, objective answer instead
  • Avoid being too verbose

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Russell is

  • Conviction around the impact matters the most to them, followed by a sense of achievement and ROI.
  • Will you ever get a clear answer from Russell

  • If they decide not to use your product, they will say no clearly.

Insights For Deal Planning

    How fast (or slow) will Russell move?

  • They can take decisions very fast if you manage to convince them.
  • Can Russell take some risk or not?

  • The risks don’t matter much to them.

You And Russell

Personality Compatibility


Other The Janssen Pharmaceutical Companies of Johnson & Johnson Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.